What is the prevalence of underdiagnosis of sleep apnea (obstructive sleep apnea)

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Sleep Apnea is Severely Underdiagnosed

Approximately 80-93% of adults with moderate to severe obstructive sleep apnea (OSA) remain undiagnosed, representing one of the most significant gaps in modern healthcare. 1

Magnitude of Underdiagnosis

The underdiagnosis of OSA is staggering across multiple populations and settings:

  • In the general U.S. adult population, nearly 80% of patients with OSA are undiagnosed, representing a massive economic and health burden 1
  • Among middle-aged adults, 93% of women and 82% of men with moderate to severe OSA have not been clinically diagnosed 2
  • In surgical populations, 92% of patients with moderate-to-severe OSA were not diagnosed by surgeons and 60% were not diagnosed by anesthesiologists before operation 3
  • Even among patients with pre-existing OSA diagnoses, 58% were not recognized by surgeons and 15% were not recognized by anesthesiologists during preoperative evaluation 3

Global Burden

The worldwide scope of this problem is enormous:

  • Globally, 936 million adults aged 30-69 years have mild to severe OSA, with 425 million having moderate to severe disease 1
  • More than 80% of adults with moderate to severe OSA remain undiagnosed worldwide 4
  • In Switzerland's HypnoLaus study, moderate-to-severe sleep-disordered breathing affected 23.4% of women and 49.7% of men 1

Clinical Implications of Missed Diagnoses

The consequences of this underdiagnosis are severe and multifaceted:

Mortality and Morbidity Impact

  • Untreated OSA leads to serious health conditions including systemic hypertension, coronary artery disease, stroke, atrial fibrillation, and congestive heart failure 1
  • Mortality risk increases substantially with the number and severity of comorbidities in undiagnosed OSA 1
  • Undiagnosed OSA is independently associated with increased likelihood of hypertension, cardiovascular disease, stroke, and diminished quality of life 5

Economic and Safety Burden

  • In 2000, an estimated 810,000 motor vehicle collisions and 1,400 fatalities in the United States were attributable to sleep apnea 4
  • Untreated patients with sleep apnea consume a disproportionate amount of healthcare resources, with expenditures decreasing after treatment 4
  • OSA is responsible for increased working and motor vehicle accidents with overall decreased quality of life 1

High-Risk Populations with Greater Underdiagnosis

Certain populations have particularly high rates of undiagnosed OSA:

  • Bariatric surgery candidates: 70-80% have OSA 1
  • Patients with transient ischemic attack or stroke: 60-70% have OSA 1
  • Patients with coronary artery disease, congestive heart failure, arrhythmias, refractory hypertension, type 2 diabetes, and polycystic ovarian disease have substantially increased rates 1

Why Underdiagnosis Persists

Several factors contribute to this massive underdiagnosis:

  • Clinical screening questionnaires and prediction algorithms miss a significant number of patients and cannot diagnose OSA without polysomnography or home sleep apnea testing 1
  • Many patients are admitted to hospitals with previous OSA diagnoses that are not reported or recognized 6
  • Healthcare providers across specialties fail to identify symptomatic patients even during preoperative evaluations 3

Critical Pitfalls to Avoid

Do not rely on clinical tools, questionnaires, or prediction algorithms alone to rule out OSA—the American Academy of Sleep Medicine strongly recommends against using these for diagnosis in the absence of objective testing 1. Even when patients screen negative or have normal BMI (studies show significant OSA prevalence even with BMI of 27 kg/m²), maintain clinical suspicion if symptoms are present [@29@].

Do not assume that absence of excessive daytime sleepiness rules out clinically significant OSA—many patients with elevated AHI lack sleepiness but remain at risk for cardiovascular complications 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.